Evotec SE (EVO)
1.68
-0.05 (2.89%)
Upcoming Events
Latest Headlines
Form 6-K Evotec SE For: Aug 13
August 13, 2026 6:07 AM - SEC Filing
Evotec and Odyssey partner on autoimmune drug discovery
August 6, 2026 6:00 AM - StreetInsider
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
August 6, 2026 2:17 AM - PR NewsWire
Niagen Bioscience taps Evotec for NB4168 preclinical drug studies
August 3, 2026 8:33 AM - StreetInsider
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
August 3, 2026 8:32 AM - BizWire
Evotec selects Navan to manage travel and expense globally
July 23, 2026 3:29 AM - StreetInsider
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
July 23, 2026 3:00 AM - BizWire
Evotec AG (EVT:GR) (EVO) PT Lowered to EUR3.50 at Deutsche Bank
July 16, 2026 6:46 AM - StreetInsider
Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold
July 16, 2026 1:52 AM - StreetInsider
Evotec (EVO) PT Lowered to $4 at H.C. Wainwright
July 15, 2026 7:35 AM - StreetInsider
TD Cowen Downgrades Evotec (EVO) to Hold
July 15, 2026 2:51 AM - StreetInsider
TD Cowen Downgrades Evotec AG (EVT:GR) (EVO) to Hold
July 15, 2026 2:19 AM - StreetInsider
Form 6-K Evotec SE For: Jul 13
July 14, 2026 6:01 AM - SEC Filing
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
July 13, 2026 3:44 PM - PR NewsWire
Form 6-K Evotec SE For: Jun 30
June 30, 2026 1:01 PM - SEC Filing
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
June 30, 2026 2:17 AM - PR NewsWire
Form 6-K Evotec SE For: Jun 17
June 17, 2026 6:04 AM - SEC Filing
Full Article List
